The hypothesis is supported by much of the published literature, which reported that the expression of PDCD10 and GCKIII kinases are positively correlated with tumor grade and aggressiveness in breast cancer and prostate cancer, while expression of STRNs is reduced in aggressive breast cancer subtypes [78,81]. Here, PDCD10 is linked to breast cancer.